Stocks and Investing Stocks and Investing
Thu, June 27, 2024

Brian Abrahams Reiterated (BIIB) at Buy and Held Target at $317 on, Jun 27th, 2024


Published on 2024-10-28 12:07:48 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Reiterated "Biogen Inc." (BIIB) at Buy and Held Target at $317 on, Jun 27th, 2024.

Brian has made no other calls on BIIB in the last 4 months.



There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 5 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $215 on, Thursday, April 25th, 2024
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $200 on, Thursday, April 25th, 2024
  • Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $214 on, Wednesday, April 17th, 2024
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $260 on, Friday, April 12th, 2024
  • Chris Schott of "JP Morgan" Maintained at Hold with Decreased Target to $240 on, Thursday, April 11th, 2024


These are the ratings of the 5 analyists that currently disagree with Brian


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 23rd, 2024
  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $294 on, Wednesday, May 22nd, 2024
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy and Held Target at $340 on, Thursday, May 16th, 2024
  • Morten Herholdt of "HSBC" Maintained at Strong Buy with Increased Target to $342 on, Friday, May 3rd, 2024
  • Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $270 on, Monday, April 29th, 2024
Contributing Sources